Cargando…
DNA hypermethylation of MAL gene may act as an independent predictor of favorable prognosis in patients with colorectal cancer
BACKGROUND: Aberrant DNA methylation could be used as biomarkers for colorectal cancer (CRC) detection and assessment of prognosis. The aim of our study was to investigate the potential possibility of MAL methylation as a prognostic biomarker for postoperative CRC patients. METHODS: We followed up 2...
Autores principales: | Liu, Xinyan, Bi, Haoran, Ge, Anqi, Xia, Tingting, Fu, Jinming, Liu, Yupeng, Sun, Hongru, Li, Dapeng, Zhao, Yashuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799055/ https://www.ncbi.nlm.nih.gov/pubmed/35116947 http://dx.doi.org/10.21037/tcr.2019.09.04 |
Ejemplares similares
-
DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients
por: Liu, Xinyan, et al.
Publicado: (2019) -
DNA Methylation in RARβ Gene as a Mediator of the Association Between Healthy Lifestyle and Breast Cancer: A Case–Control Study
por: Wang, Xuan, et al.
Publicado: (2020) -
PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis
por: Sun, Hongru, et al.
Publicado: (2019) -
Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer
por: Zhang, Yuanyuan, et al.
Publicado: (2021) -
Insulin-like growth factor 2 hypermethylation in peripheral blood leukocytes and colorectal cancer risk and prognosis: a propensity score analysis
por: Sun, HongRu, et al.
Publicado: (2023)